Clinical trials are designed around percent body weight reduction, achievement of predefined thresholds such as 10 or 15 percent loss, and improvements in obesity-related comorbidities
Some immunobiotics can also alleviate NASH and liver fibrosis induced by a methionine-choline-deficient (MCD) diet by reducing intestinal damage and permeability in mice
For example, Novo Nordisk is exploring semaglutide in large-scale clinical trials for Alzheimers, while other biotech startups are assessing GLP-1 analogs in treating opioid dependency
7 Compared to other antidiabetic drugs, GLP-1 RAs have the advantage of only being pharmacologically active when blood glucose levels are high
The general targets for adults with type 2 diabetes are: Pre-meal glucose : 47 mmol/L Fasting plasma glucose : 57 mmol/L Post-prandial glucose (2 hours after meals): less than 8.5 mmol/L HbA1c : individualised, but typically 4853 mmol/mol (6.57.0%) for most adults These targets may be adjusted based on individual circumstances, including age, comorbidities, and hypoglycaemia awareness
_edited.jpg)
